Novavax stock jumps 50% as Sanofi deal kicks off turning point for struggling vaccine makerCNBC • 05/13/24
Press Release: Sanofi adds over €1 billion for biomanufacturing to €2.5 billion already committed in major projects in France to support health sovereigntyGlobeNewsWire • 05/13/24
Novavax shares skyrocket after billion-dollar licensing deal with SanofiProactive Investors • 05/10/24
Novavax shares jump 40% on $1.2 billion licensing deal with Sanofi despite Q1 lossesInvezz • 05/10/24
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shotsCNBC • 05/10/24
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination VaccinesPRNewsWire • 05/10/24
Press Release: Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine and develop novel flu-COVID-19 combination vaccinesGlobeNewsWire • 05/10/24
INHIBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inhibrx, Inc. - INBXBusiness Wire • 05/09/24
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant RSV hospitalizationsGlobeNewsWire • 05/02/24